Japan Tissue Engineering Co., Ltd. (JP:7774) has released an update.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge-fund level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Japan Tissue Engineering Co., Ltd. and Sysmex Corporation have signed a basic agreement to enhance manufacturing capabilities for regenerative medicine and cell therapy through mechanization and automation. This collaboration aims to tackle the challenges in the industry by leveraging innovative technologies, ultimately contributing to the sustainability and growth of regenerative medicine in Japan. The partnership seeks to provide a stable supply of high-quality regenerative medical products by overcoming production bottlenecks.
For further insights into JP:7774 stock, check out TipRanks’ Stock Analysis page.